Fulcrum Therapeutics (FULC) Net Margin (QoQ) (2020 - 2023)
Fulcrum Therapeutics (FULC) Net Margin (QoQ) (2020 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Fulcrum Therapeutics | 285.43 Mn | 285.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -178,474.00 |
| Sep 30, 2023 | -46,168.00 |
| Jun 30, 2023 | 764,417.00 |
| Mar 31, 2023 | 1.77 Mn |
| Dec 31, 2022 | -2.58 Mn |
| Sep 30, 2022 | -40,622.00 |
| Jun 30, 2022 | 174,321.00 |
| Mar 31, 2022 | -261,908.00 |
| Dec 31, 2021 | 94,743.00 |
| Sep 30, 2021 | -108,766.00 |
| Jun 30, 2021 | -38,928.00 |
| Mar 31, 2021 | -5,842.00 |
| Dec 31, 2020 | 60,667.00 |
| Sep 30, 2020 | -24,183.00 |
| Jun 30, 2020 | 167,602.00 |